- Home
- APPN vs ARWR Comparison
APPN vs ARWR Comparison
Compare APPN & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APPN
- ARWR
- Stock Information
- Founded
- APPN 1999
- ARWR 2003
- Country
- APPN United States
- ARWR United States
- Employees
- APPN N/A
- ARWR N/A
- Industry
- APPN Computer Software: Prepackaged Software
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- APPN Technology
- ARWR Health Care
- Exchange
- APPN Nasdaq
- ARWR Nasdaq
- Market Cap
- APPN 2.6B
- ARWR 2.6B
- IPO Year
- APPN 2017
- ARWR 1993
- Fundamental
- Price
- APPN $33.34
- ARWR $19.90
- Analyst Decision
- APPN Hold
- ARWR Buy
- Analyst Count
- APPN 7
- ARWR 11
- Target Price
- APPN $40.00
- ARWR $43.33
- AVG Volume (30 Days)
- APPN 516.5K
- ARWR 2.5M
- Earning Date
- APPN 02-19-2025
- ARWR 02-10-2025
- Dividend Yield
- APPN N/A
- ARWR N/A
- EPS Growth
- APPN N/A
- ARWR N/A
- EPS
- APPN N/A
- ARWR N/A
- Revenue
- APPN $617,022,000.00
- ARWR $2,500,000.00
- Revenue This Year
- APPN $14.93
- ARWR $3,336.78
- Revenue Next Year
- APPN $11.07
- ARWR $124.29
- P/E Ratio
- APPN N/A
- ARWR N/A
- Revenue Growth
- APPN 13.14
- ARWR N/A
- 52 Week Low
- APPN $26.28
- ARWR $17.05
- 52 Week High
- APPN $43.33
- ARWR $36.72
- Technical
- Relative Strength Index (RSI)
- APPN 47.28
- ARWR 49.40
- Support Level
- APPN $30.79
- ARWR $17.57
- Resistance Level
- APPN $41.05
- ARWR $21.84
- Average True Range (ATR)
- APPN 1.93
- ARWR 1.06
- MACD
- APPN 0.06
- ARWR 0.11
- Stochastic Oscillator
- APPN 24.85
- ARWR 54.57
About APPN Appian Corporation
Appian is a low-code enterprise platform-as-a-service company focusing on business process management. The Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. Most of Appian's revenue is subscription based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform, Appian Cloud.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.